The Belgian Debt Agency informs that the following 3 OLO lines will be auctioned on Monday 25 August 2025 :1.Description : OLO 3.00% 22/06/2033ISIN code : BE0000357666OLO number : OLO 97Outstanding : EUR 20 188 000 000.002.Description : OLO 2.85% 22/10/2034ISIN code : BE0000360694OLO number : OLO 100Outstanding : EUR 17 874 000 000.003.Description : OLO 3.50% 22/06/2055ISIN code : BE0000361700OLO number : OLO 101Outstanding : EUR 9 033 000 000.00Payment date will be 27 August 2025. On Friday 22...

From 25 to 29 August 2025, the Belgian Federal Public Service Chancellery of the Prime Minister will receive a delegation of Japanese journalists in the context of country branding campaign ‘Belgium. Open for Business’. The purpose of the visit is to discover the ‘Belgium Health and Biotech Valley’. Some of Japan's largest media outlets, including Yomiuri Shimbun, Nikkei Business and NHK, will be taking part.

The Belgian Debt Agency informs that it has accepted bids of Treasury certificates for a total amount of EUR 3.202 billion, distributed into the following lines :ISIN Code : BE0312803753 - 13/11/2025Amount taken (EUR billion) : 1.222Weighted average yield : 1.916%Bid-to-cover ratio : 2.27ISIN Code : BE0312815872 - 13/08/2026Amount taken (EUR billion) : 1.980Weighted average yield : 1.966%Bid-to-cover ratio : 1.57See our Refinitiv page BELG/TC or Bloomberg page BEDA - TC Auctions - Results.

Press release from the Belgian Debt Agency

Press release from the Belgian Debt Agency

The Belgian Debt Agency informs that it has accepted bids for a total amount of EUR 0.502 billion, distributed into the following lines :

The Belgian Debt Agency informs that the following 2 OLO lines will be auctioned on Friday 01 August 2025 for a maximum amount of EUR 500 million :

The Belgian Debt Agency informs that it has accepted bids for a total amount of EUR 3.008 billion, distributed into the following lines :

The number of temporarily unavailable medicines decreased in 2024: that is one of the main conclusions from the annual report of the Federal Agency for Medicines and Health Products. The year 2024 was also marked by the Belgian Presidency of the Council of the European Union. A unique opportunity for the FAMHP to strengthen its role at European level. At the same time, our other activities also continued. The FAMHP’s annual report provides an overview of that progress.